Clinical Trial Update: Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults. [Phase 2]

View source ↗

Summary

Phase 2 study in adults with precursor B-cell acute lymphoblastic leukemia adds blinatumomab to prephase and consolidation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Precursor B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: ALL, Adult | Phase 2 | Status: ACTIVE_NOT_RECRUITING